🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2025-08-10
Trial ID
NCT07106671
Treatments Being Tested
This phase Ib/II trial studies the best dose and side effects of siltuximab...
Status
Completed
Location
Emory University Hospital Midtown
Start Date
2020-01-17
Trial ID
NCT04191421
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of siltuxi...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00402181
Treatments Being Tested
The purpose of this study is to evaluate of the study of different CNTO 328...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT00412321
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of siltuxima...
Status
Terminated
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00385827
Treatments Being Tested
Researchers are looking for new ways to treat people with relapsed or refra...
Status
Recruiting
Location
Rigshospitalet ( Site 0802)
Start Date
2026-05-18
Trial ID
NCT07570173
The purpose of this study is to evaluate the effects of siltuximab on immun...
Status
Completed
Location
Benaroya Research Institute
Start Date
2016-03-08
Trial ID
NCT02641522
Treatments Being Tested
The purpose of Part 1 of this study is to assess the safety and tolerabilit...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT02074800
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of siltuxi...
Status
Completed
Location
Multiple Locations
Start Date
2012-03-01
Trial ID
NCT01484275
Treatments Being Tested
The purpose of the study is to evaluate the safety and effectiveness of sil...
Status
Terminated
Location
Moffitt Cancer Center
Start Date
2023-02-15
Trial ID
NCT05316116
Treatments Being Tested